• JPMorgan Chase disclosed it crossed above 5% of Abivax on June 22, 2026.
• Stake totaled 4,908,891 shares, equal to 6.15% of capital, 5.98% of voting rights.
• Move reflected higher holdings by assimilation, including depository receipts, third party depository receipts where right of use held, equity swaps.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on June 25, 2026, and is solely responsible for the information contained therein.